Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Shandong ranks #42,922 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.
- #42,922
- of 49,997 US assignees by volume
- 16th percentile
- by Innovation Score (25.1/100)
- 11.5
- avg claims per patent
- +100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R42922 · Foreign Corporation #42,922 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #42,922/49,997
- PHOTO-FINISH Sgce
- CPC-NARROW C07D · 4 areas
- INNOV-THIN 25.1/100
- CLAIMS-PAR 11.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sgce LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Shandong’s 25.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Shandong
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Shandong Luoxin… · this assignee 25
Shandong Luoxin… · this assignee
25 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Shandong's Innovation Score is 25.1/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Shandong?
Each dot is one of Shandong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shandong’s own 11.5 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Shandong's grants concentrate
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). By volume, Shandong sits between Sgce LLC and Shanghai Eastsoft Microelectronics Co., Ltd..
Shandong's three-year grant acceleration
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Shandong's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sgce
Sgce LLC
6 patents
- SGD
SGD S.A.
6 patents
- Shandong Academy…
Shandong Academy OF Agricultural Machinery Sciences
6 patents
- Shandong Institut…
Shandong Institute OF Quantum Science AND Technology Co., Ltd.
6 patents
- Shandong NHU Phar…
Shandong NHU Pharmaceutical Co., Ltd.
6 patents
- Shandong Zhonghai…
Shandong Zhonghai Pharmaceutical Co. Ltd
6 patents
- Shang HAI PAN SHI…
Shang HAI PAN SHI TOU ZI Guan LI YOU Xian Gong SI
6 patents
- Shanghai Eastsoft…
Shanghai Eastsoft Microelectronics Co., Ltd.
6 patents
- Shandong Luoxin P… ◀
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
6 patents
What this shows Shandong holds 6 patents at rank #42,809, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Shandong
By rank, the assignees closest to #42,809 in granted patent volume.
- Sgce LLC #42,805 · 6 patents
- SGD S.A. #42,806 · 6 patents
- Shandong Academy OF Agricultural Machinery Sciences #42,807 · 6 patents
- Shandong Institute OF Quantum Science AND Technology Co., Ltd. #42,808 · 6 patents
- Shandong NHU Pharmaceutical Co., Ltd. #42,810 · 6 patents
- Shandong Zhonghai Pharmaceutical Co. Ltd #42,811 · 6 patents
- Shang HAI PAN SHI TOU ZI Guan LI YOU Xian Gong SI #42,812 · 6 patents
- Shanghai Eastsoft Microelectronics Co., Ltd. #42,813 · 6 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Shandong's primary technology class.
Shandong's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 16th percentile higher than 16% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 16.7% |
| 2019 | 1 | 16.7% |
| 2020 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Which technologies does Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.'s patent record in context - here's where to go next.
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #42,922 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. against Sgce LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 25.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.